Multibagger Securities Research & Advisory Pvt Ltd

22/05/2026

Choice Overload — The Bias That Quietly Paralyses Indian Retail Investors
In May 2026, the average Indian retail investor with a demat account can choose between roughly 5,000 listed equities on the NSE and BSE combined, ~1,500 distinct mutual fund schemes across more than 44 AMCs registered with AMFI, hundreds of NCDs, dozens of PMS managers, 100+ SEBI-registered AIFs, listed and unlisted REITs/InvITs, multiple ETF families, sovereign and corporate bonds across the RBI Retail Direct portal, and a growing menu of internationally accessible US ETFs through LRS-linked platforms. On paper, that abundance looks like progress: more options must mean better outcomes, because the investor can always pick exactly what suits her objective.
The behavioural-finance research of the last twenty-five years says exactly the opposite. When the option set crosses a certain cognitive threshold, decision quality collapses.

Iyengar & Lepper’s 2000 jam study and Sethi-Iyengar’s 2004 401(k) evidence show that wider option sets paralyse decision-makers. With ~1,500 MF schemes and 5,000+ listed stocks, Indian retail investors face an extreme choice-overload landscape. A four-step counter-measure checklist, and an educa...

22/05/2026

If a value investor were allowed to study exactly one governance disclosure in an Indian annual report, the smart choice would not be the audit report, not the board composition table, and not even the related-party schedule. It would be the small, easily-skipped paragraph mandated by Section 197(12) of the Companies Act, 2013 read with Rule 5(1)(i) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 — the disclosure that publishes the ratio of the Managing Director’s remuneration to the median employee’s remuneration. It is a number Indian regulators forced into the public domain for one reason: to hand minority shareholders a single, comparable, year-on-year forensic test for managerial pay discipline. Most retail investors never read it. The ones who do, read businesses very differently.

The CEO-to-Median-Employee Pay Ratio mandated by Companies Act Section 197(12) read with Rule 5(1)(i) is one of the highest signal-to-noise governance disclosures in any Indian annual report. This educational piece decodes the metric, shows how to read its three-to-five-year arc, and illustrates the...

22/05/2026

📅 Published May 22, 2026 (Friday) | 8:00 AM IST

The Question That Started a 365-Stock Study

In 2014, Christopher Mayer, then a portfolio manager at Bonner & Partners and now at Woodlock House Family Capital, set out to answer one question that every long-term investor secretly cares about: which stocks turn ₹1 lakh into ₹1 crore? Not 5x. Not 10x. A clean 100x — what Thomas Phelps had called, in his obscure 1972 classic 100 to 1 in the Stock Market, the "hundred-bagger."

Mayer pulled every U.S. stock that had compounded at 100x or more between 1962 and 2014. The sample came to 365 names. He then went line by line through their fundamentals at the moment the 100-bagger journey began — not at the end, where everyone already knows the answer.

Christopher Mayer's 365-stock empirical study extracted seven attributes that predicted 100x compounders. Titan Biotech FY25 illustrates five of the seven on a small-cap Indian balance sheet.

21/05/2026

If you have ever opened your portfolio after a bad market day and felt the loss with a sharper, longer, more visceral pain than the equivalent gain on a good day, you have lived inside the most foundational cognitive bias in behavioural finance: negativity bias. Roy Baumeister, Ellen Bratslavsky, Catrin Finkenauer and Kathleen Vohs published the canonical synthesis in 2001, in their landmark paper "Bad Is Stronger Than Good" (Review of General Psychology, Vol. 5, No. 4, 323–370). After reviewing decades of psychology research across emotion, cognition, learning, memory, marriage, parenting and decision-making, they concluded with one almost universal finding: bad events, bad feedback, bad outcomes and bad information have substantially greater psychological impact than equivalently strong good events. Their estimate, repeated across multiple sub-domains, was that the negative weight ratio sits somewhere between 2:1 and 5:1.

Roy Baumeister and colleagues showed in 2001 that bad events register roughly three times more strongly than good ones in the human mind. For Indian retail investors, this asymmetry explains panic selling, F&O double-downs, SIP discontinuations during drawdowns and the weight of a single negative he...

21/05/2026

When the National Stock Exchange of India crossed the eleven-crore registered investor mark in early 2026 — having scaled from roughly three crore in 2020 — a sobering reality became impossible to ignore. The vast majority of these new entrants do not read annual reports. Among the small minority who do open one, almost none turn to the corporate governance section. And among those who do read the governance section, fewer still understand the single most powerful sub-body inside an Indian listed company: the Audit Committee.

This is the body where Indian annual reports actually get vetted. Where quarterly results, related party transactions, internal-control adequacy, whistleblower complaints, the appointment and removal of statutory auditors, and the integrity of the entire financial-reporting machinery are reviewed before being published to the world. The Audit Committee is, in plain language, the shareholders' line of defence inside the boardroom.

How to read an Indian listed company's Audit Committee disclosure in 5 minutes — composition, financial-literacy, meeting-cadence, attendance and terms-of-reference tests, illustrated with Titan Biotech FY25 audited governance markers.

21/05/2026

When Charles T. Akre Jr. — the soft-spoken Virginia investor who turned a small boutique into a multibillion-dollar compounding machine — was asked at a 2011 Google Talk how he picked stocks that returned 20%+ for decades, he reached not for a spreadsheet but for a wooden three-legged milking stool, set it on the table, and said: a compounder rests on three legs, and if any one leg snaps, the whole thing tips over. That stool — Akre's mental shorthand for an entire philosophy — is the cleanest compounder-picking framework in modern value investing. Almost no Indian retail investor has ever heard of it.

Every multibagger I have ever held over twenty-eight years of Indian small-cap investing — Swiss Glascoat, KPR Mills, Mold-Tek Packaging, Chaman Lal Setia, Titan Biotech — passed Akre's three-legged test long before it appeared on any screener. The framework is so simple it looks naive. It is the most demanding filter I know.

Chuck Akre's three-legged stool — extraordinary business, exceptional management, glorious reinvestment runway — distils the compounder-picking framework. Titan Biotech's FY25 audited numbers map cleanly onto all three legs.

20/05/2026

Some of the greatest fortunes in American corporate history were not built by the most charismatic operators, the loudest brand-builders, or the most aggressive empire-acquirers. They were built by quiet, almost reclusive chief executives who understood one thing that nobody around them was paying attention to — that the job of running a public company is, at its core, a capital-allocation job. In 2012, a Boston investor named William N. Thorndike studied eight such CEOs and wrote a slim, dense book called The Outsiders: Eight Unconventional CEOs and Their Radically Rational Blueprint for Success. Over the years I have come back to that book more than to almost any other investing text, because it answers a question that the standard valuation curriculum ducks: once a business is profitable, what does management do with the money?

That is the real Indian small-cap problem. Profits are common in our market. Compounded shareholder returns over a decade are not.

William Thorndike's 2012 study of eight outsider CEOs revealed that compounding shareholder wealth is a capital-allocation discipline — not an operating one. Titan Biotech's FY25 audited numbers fit the five-choice template.

19/05/2026

India now has over 11 crore unique investors registered with NSE as of 2025 — up from barely 3 crore at the start of the decade. The 2024 SEBI study on the equity Futures & Options segment found that 93% of individual F&O traders lost money, with aggregate retail F&O losses crossing ₹1.81 lakh crore over FY22–FY24. The simultaneous SEBI clampdown on finfluencers in 2024–25 was the regulator's polite way of saying that the average Indian investor is buying narratives faster than they are reading balance sheets. The single most under-used skill in the country today is the willingness to spend forty-five minutes inside an annual report looking for forensic red flags before pressing a buy button.

James Montier's Modified C-Score is a six-variable forensic detector for accounting manipulation. We decode all six variables, contrast a disciplined manufacturer with a generic red-flag profile, and show how Titan Biotech FY25's audited numbers score 0/6 — an educational illustration only, not a ...

19/05/2026

Most Indian retail investors look at a quarterly result, see a margin dip or a flat top-line, and immediately ask the wrong question: "Has the business broken?" The right question — the one Tom Russo has been asking for forty years at Gardner Russo & Quoss while compounding capital in Nestlé, Heineken, Pernod Ricard and Berkshire — is: "Is management spending today's reported earnings to widen tomorrow's moat?" That single reframing is the heart of a value-investing principle I want every long-term Indian investor to internalise this morning: Capacity to Suffer.

The Principle: Capacity to Suffer, in Plain English

Thomas A. Russo, the partner at Gardner Russo & Quoss whose family-controlled compounders portfolio has run for over four decades, coined the phrase Capacity to Suffer to describe a very specific corporate trait.

18/05/2026

In April 2002, Stanford social psychologist Emily Pronin and her colleagues Daniel Lin and Lee Ross published a paper in the Personality and Social Psychology Bulletin with a deceptively simple title: "The Bias Blind Spot: Perceptions of Bias in Self Versus Others." Across three experimental studies, they documented something almost embarrassing about the human mind. When subjects were given a list of well-known cognitive biases — self-serving attribution, halo effects, in-group favouritism, dissonance reduction — they confidently rated other people as much more susceptible to those biases than themselves. And here is the kicker: the gap did not shrink when participants were first taught what each bias was. Education made it worse. The more people knew about cognitive bias, the more confidently they detected it in everyone except the person they saw in the mirror.

Pronin, Lin & Ross's 2002 Stanford research on the meta-bias that hides every other cognitive error — why education makes the blind spot worse, the SEBI F&O data that shows ₹1.81 lakh crore of Indian retail losses for what they really are, the six external-structure counter-measures, and how Tit...

18/05/2026

The Most Powerful Governance Signal That 99% of Indian Retail Investors Never Read

India's equity investor base has multiplied roughly four-fold in seven years — from ~3 crore unique investors in FY18 to over 11 crore registered NSE investors today. The democratisation is real, the participation is durable, and the inflows through SIPs have become a genuine structural force on Dalal Street. Yet a sobering parallel statistic, drawn from SEBI's own 2023–24 study of the equity Futures & Options segment, reminds us that activity is not the same as discipline: 9 out of 10 individual F&O traders in India incurred net losses. The aggregate F&O loss for individual traders crossed ₹1.81 lakh crore between FY22 and FY24 alone. The market is bigger, faster, louder — and for most participants, more punishing.

Against this backdrop, the simplest edge an Indian long-term investor can develop is not a new chart pattern or a clever algorithm. It is a forensic reading of the audited Annual Report.

How to read the Vigil Mechanism / Whistleblower Policy section of an Indian Annual Report — the three overlapping laws, the five-component checklist, and what Titan Biotech FY25's governance markers illustrate. Educational only — not a buy/sell call.